President Trump gave brief remarks to supporters at the Asheville Regional Airport landing zone, echoing much of what he said in Charlotte, touting the stock market, the employment numbers, and saying the pandemic will go away.
The President also again predicted a vaccine will be announced shortly.
“The vaccines are going to be, I believe, announced very soon,” Trump said, before praising convalescent plasma, calling it an “incredible thing.”
The President also said he expects the economic comeback from coronavirus to be strong next year, saying “next year we are going to have one of the best years economically and in other ways that we have ever had before.”
Some background: On Saturday, Trump accused, without providing any evidence, the US Food and Drug Administration of deliberately delaying coronavirus vaccine trials, pressuring the man he had picked to head the agency.
“The deep state, or whoever, over at the FDA is making it very difficult for drug companies to get people in order to test the vaccines and therapeutics,” Trump tweeted, continuing to push his unfounded theory that there is a “deep state” embedded within the government bureaucracy working against his reelection.
He accused the agency of delaying a vaccine for the virus until after the fall election, tweeting, “Obviously, they are hoping to delay the answer until after November 3rd. Must focus on speed, and saving lives!” Trump ended his tweet by tagging the Twitter account of FDA Commissioner Dr. Stephen Hahn, who he nominated last year to take up the role.
Hahn assured Americans earlier this month that the agency “will not cut corners” to approve a vaccine.
Trump has promised that a vaccine would be available by the end of the year, though vaccinologists told CNN that timeline is unrealistic. And his latest comments won’t allay the fears some experts and Americans have that the administration will rush to prepare a vaccine at the expense of science and safety.
The FDA doesn’t conduct the trials itself, but instead oversees the people who do, according to the agency. As CNN previously reported, one vaccine candidate, developed by Moderna and the National Institute of Allergy and Infectious Diseases, moved to phase 3 clinical trials late last month.